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ABSTRACT

Background: In an energy-limited environment, caloric investments in one characteristic should tradeoff with investments in other characteristics. In high pathogen ecologies, biasing energy allocation towards immune function over growth would be predicted, given strong selective pressures against
early-life mortality.
Methodology: In the present study, we use flow cytometry to examine trade-offs between adaptive immune function (T cell subsets, B cells), innate immune function (natural killer cells), adaptive to innate
ratio and height-for-age z scores (HAZ) among young children (N ¼ 344; aged 2 months–8 years) in
the Bolivian Amazon, using maternal BMI and child weight-for-height z scores (WHZ) as proxies for
energetic status.
Results: Markers of adaptive immune function negatively associate with child HAZ, a pattern most significant in preadolescents (3þ years). In children under three, maternal BMI appears to buffer immune
and HAZ associations, while child energetic status (WHZ) moderates relationships in an unexpected
direction: HAZ and immune associations are greater in preadolescents with higher WHZ. Children
with low WHZ maintain similar levels of adaptive immune function, but are shorter compared to high
WHZ peers.
Conclusions: Reduced investment in growth in favor of immunity may be necessary for survival in high
pathogen contexts, even under energetic constraints. Further, genetic and environmental factors are
important considerations for understanding variation in height within this population. These findings
C The Author(s) 2020. Published by Oxford University Press on behalf of the Foundation for Evolution, Medicine, and Public Health. This is an Open
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prompt consideration of whether there may be a threshold of investment into adaptive immunity required for survival in high pathogen
environments, and thus question the universal relevance of height as a marker of health.
Lay Summary: Adaptive immune function is negatively associated with child height in this high pathogen environment. Further, low
weight-for-height children are shorter but maintain similar immune levels. Findings question the relevance of height as a universal
health marker, given that costs and benefits of height versus immunity may be calibrated to local ecology.
K E Y W O R D S : life history theory; developmental plasticity; ecological immunology; Tsimane

1. BACKGROUND AND OBJECTIVES
Energy available to organisms is limited and allocated to competing physiological demands in ways that optimize biological
fitness. All else equal, energetic investment in one characteristic
should trade-off with investment in other characteristics [1–3].
Natural selection can produce adaptations for managing tradeoffs in species-typical ways, but it can also select for norms of
reaction that manage allocations to fit local ecological contexts
through developmental plasticity, allowing individuals to better
approach the ‘optimal’ energy allocation strategy for a particular
environment [4]. For example, given the strong selective pressure against infant mortality, early investment in immune function should be prioritized despite consequences for competing
energetic requirements, like growth. This may be particularly salient in a high pathogen environment, where investment in the
adaptive arm of the immune system, which confers long-lasting
specific immunity, would be critical for surviving this early
period [5].
Growth and immune trade-offs have been studied in humans
and across vertebrate taxa [6]. In humans, numerous studies
have shown that chronic immune activation [7, 8], and overall
pathogen burden are associated with growth stunting [9, 10]. At
young ages, while there may be early developmental origins of
growth–immune associations, these relationships are often
complex, and may be convoluted by changes occurring across
multiple landscapes (e.g. maturational tempo, pathogen exposure, physical activity and diet) within a relatively narrow window
of time. For example, in studies of infants in the Gambia [11]
and Northern Kenya [12], researchers found that evidence of immune activation, as measured by (1) intestinal permeability and
mucosal enteropathy and (2) immunoglobulin A (salivary), respectively, showed impaired growth, and that levels of immunoglobulins A, G and M rapidly increased with age [11]. Panter–
Brick and colleagues similarly documented an age-related increase in IgG levels in a group of Nepali infants (n ¼ 86), which
varied by socioeconomic status, and was associated with lower
weight-for-age [13]. However, the authors also found that mucosal damage, which was associated with impaired growth in
height, was most severe among middle-class children, leading
to the conclusion that nutritional constraints may mask or confound relationships between immune function and linear
growth.

To date, many of the relevant studies have utilized either generalized markers of inflammation, or measures of immunoglobulins, and none that we are aware of include direct
measurements of the leukocytes responsible for long-term
adaptive immune function, including naı̈ve and memory T cells
and B cells. Numerous questions remain about how different
aspects of immune function and activation relate to growth,
whether these represent short- or long-term accommodations,
and how factors like how nutritional environment, or energy
availability, buffer or exacerbate these effects. Growth–immune
trade-offs might represent short-term accommodations to temporary resource shortages, or longer-term phenotypic adjustments to expected future conditions [14]. In the short term, in
addition to the direct costs of immune activation, anorexia
associated with sickness behavior or gastrointestinal distress
may cause sick children to eat less and absorb less nutrients
[15], reducing energy available for growth. Particularly when intake is limited, fat stores may represent critical energy reserves
upon which the body draws to fuel metabolic processes associated with growth and immune responses to infectious disease
[16, 17]. Having larger energy intake or energy stores may allow
for greater investment across multiple traits simultaneously. As
a consequence, at the individual level there may be positive covariation among life history traits in individuals with ample
resources [18]. In contrast to these short-term accommodations, long-term adjustments in expectation of future trade-offs
may play out quite differently. For example, if short-term immune activation serves as a cue to future energy needs, we
might expect individuals to shift energy into immune function
and away from height, even in the absence of immediate energy
shortages. We might also expect that short-term immune activation could lead to increases in energy storage, and therefore
future fat accumulation [10].
One way to address the question of short- versus long-term
accommodations and trade-offs is to examine multiple aspects
of immunity that represent both short-term responses and
long-term investments. Previous studies have found that different immune markers associate with growth on different timescales. For example, Urlacher et al. [10] found that a marker of
acute inflammation associated with growth over one week, and
was mediated by fat reserves, while immunoglobulin levels
were associated with growth over months, and with overall
height-for-age z scores (HAZ).
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Here, we take a similar approach in examining both innate
and adaptive markers. However, in contrast to past studies, we
use flow cytometry to directly characterize leukocyte populations, the cells responsible for antibody production and cellular
responses. This characterization includes both cells indicative
of past exposures (non-naı̈ve cells) and cells that represent immunological resources which have not yet been activated (naı̈ve
cells). In this article, we: (i) measure multiple immune markers
in peripheral leukocytes (i.e. CD4þ/CD8þ, naı̈ve and non-naı̈ve
and total T cells, B cells and natural killer (NK) cells) that characterize specific components of both adaptive and innate immune function and (ii) examine whether maternal or child
energetic status, as measured through weight-for-height (WHZ)
(child) and body-mass-index (mother), influence potential
trade-offs between the child’s immune function and height
(HAZ).

1.1 Measuring immune function in relation to growth–
immune trade-offs
The human immune system is composed of innate and adaptive arms, which differ in their time-variant costs, time to reactivity and precision [19]. The arms of the immune system
operate in an integrated way and in coordination with other
organ systems (e.g. endocrine), with adaptive immune function
in large part serving as an extension of, and directed by, the innate arm of the immune system [20, 21]. Innate immune functions are the body’s first-line non-specific defense mechanisms
which are activated immediately upon encountering a foreign
pathogen. Because they are generally applicable and immediately available, in many senses the costs of innate immunity may
be seen as low, but innate responses also ultimately cause
more collateral damage to surrounding cells and tissue, leading
to faster rates of senescence [22–24]. By comparison, sloweracting adaptive immune responses require higher initial investment into the physiological mechanisms and systems that support them, including the production, selection and
maintenance of pools of diverse B- and T-cell variants, many of
which may never encounter a matching antigen and thus never
be used [25, 26]. However, responses of the adaptive immune
system are highly specialized, and usually cause little collateral
damage. The adaptive immune system is also increasingly
being recognized for its importance in immunological repair of
cells and tissues [27]. The thymus, a major organ of the adaptive immune system, is the primary site of T cell development
and maturation [28, 29]. That functional thymic volume peaks
within the first year after birth, suggests this early period is a
critical window for investment in adaptive immunity [28].
The innate immune response is highly sensitized, and can be
hyper-variable across days due to even minor fluctuations in environmental stimuli [30]. This sensitization makes it hard to
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distinguish acute innate responses to short-term ecological
stressors from longer-term calibration of the innate immune
system to local ecological context. The relatively slower and
less-generalized responses of the adaptive immune system suggest that, in cross-sectional studies, measures of adaptive immune function or the relative balance of adaptive to innate
immune function may more reliably reflect the way the immune
system is calibrated, and may thus provide a more accurate
metric against which traits like growth may trade-off against.

Box 1. Components of the innate and
adaptive immune system examined in this
study
Immune arm
Innate immunity
NK cells

Main activity

Main target

Kill missing-self or
antigen-presenting
cells

Viral; cellmediated

Adaptive immunity
T cells
CD4þ (help- Secrete cytokines and
er T)
function to stimulate
differentiation and
proliferation of numerous immune cells
CD8þ (cyto- Kill antigen-presenttoxic T)
ing cells
Naı̈ve cells

Un-activated CD4þ
or CD8þ; have not
yet encountered cognate antigen
Non-naive cells Activated CD4þ or
CD8þ; antigenspecific; long-lived
B cells
Antibody production

Aid in both
cell-mediated
and humoral
processes
Tumor and virally-infected;
cell-mediated
Dependent on
cell type

Dependent on
cell type
Humoral

1.2 Hypothesis and predictions
Immuno-development early in life is in competition with
growth, given that both require substantial energetic investment. We hypothesize that in high pathogen environments,
where the cost of inadequate immune function is likely higher
than smaller stature, we should see trade-offs between these
life history features, and these trade-offs may be buffered by adequate resources. Specifically, we hypothesize that markers of
adaptive immune function will trade-off against height, visible
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in this window of somatic and immunologic development, and
that this trade-off will be moderated by energy availability. Data
from the Tsimane, an energy-limited subsistence population in
lowland Bolivia facing high pathogen loads [31], will be used to
test the predictions that (P1) adaptive immune cell counts will
be inversely associated with child HAZ. Furthermore, using the
relative balance of investment into adaptive cellular immunity
(i.e. B and T cell counts) to innate cellular immunity (i.e. NK
cell counts) as a proxy for longer-term investment in costlier immune responses, we predict that (P2) a higher ratio of adaptive
to innate immunity will associate with shorter stature. Finally,
we predict that (P3) energetic status (proxied by child WHZ and
maternal body mass index) will moderate associations between
height and immune function, such that children with higher energetic status will be buffered and show a weaker trade-off (i.e.
show weaker associations) between adaptive immune markers
and height.

2. METHODOLOGY
2.1 Study population and data collection
2.1.1 The Tsimane of Bolivia. The Tsimane are foragerhorticulturalists (population 16 000) that live in the Beni
Department of Bolivia, in the lowlands comprising the Amazon
basin. Tsimane inhabit over 90 villages, most of which do not
have access to electricity, running water or comprehensive
waste management [32, 33]. Their diet is relatively lean, as they
subsist mainly on plantains, rice, sweet manioc and corn from
slash-and-burn horticulture, fish and wild game, occasionally
supplemented by market goods such as refined sugar, salt and
cooking oil [32, 34]. Despite evidence of child and adult stunting, wasting is uncommon; mean adult BMI is 23.6 for both
sexes [31, 35]. From an early age, children are exposed to an
array of pathogens, and parasitic infections among the Tsimane
are common [36]. About half of Tsimane men and women have
anemia, with children and adolescents showing the highest risk
(56% for girls, 63% for boys) [37].
Given the high transmission rate of multiple pathogens in
the Tsimane environment, investment in immune defenses is
also high, with children exhibiting a concomitant early peak in
humoral response (e.g. immunoglobulin-E, IgE) associated
with helminthic infection compared to populations with lower
transmission rates [36]. In general, Tsimane have higher levels
of numerous immune components, including white blood cells
(WBCs), erythrocyte sedimentation rate, B cells and NK cells
than do Americans at all ages [31]. On average, 16% of WBCs
are eosinophils, consistent with high levels of parasitic infection, as compared with a US reference range <5%, with approximately 85.9% of the population in eosinophilia by US standards
[38]. Antibodies related to infection are also high among
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Tsimane: immunoglobulin-G (IgG) levels are about twice as
high, and IgE is about 100 times higher than mean US levels
[36].

2.1.2 participants. Data for this study were collected as part
of the Tsimane Health and Life History Project (THLHP), a longitudinal study of health and aging that began in 2002 [32]. The
sample includes 344 children aged 2 months–8 years (55% female, median age 5 years) from 28 villages (see Table 1 for descriptive statistics). Participants were seen in the stationary
THLHP clinic in San Borja (the closest market town to sampled
villages), accompanied by a parent between mid-March and
early July of 2011, whereupon participants were seen by THLHP
physicians and given routine physical exams, which included
patient history, symptom investigation, demographic and anthropometric information. A blood sample was taken as a part
of this visit, a portion of which was used for assessing immune
function.
The study was approved by the Tsimane Government (Gran
Consejo Tsimane) and village leaders. Study protocols were
approved by the Tsimane Government and IRBs at the
Table 1. Descriptive statistics
Variables

Sex (% female)
Age (years)
Child’s BMI (kg/m2)
Mother’s height (cm)
Mother’s BMI (kg/m2)
Respiratory infection (%
infected)
Parasite analyses (n ¼ 246)
Helminthic parasites (%
infected)
Protozoal parasites (%
infected)
Leukocytes (103 per ml)
T cell count (103 per ml)
Naı̈ve T cell count (103
per ml)
CD4þ cell count (103 per
ml)
CD8þ cell count (103 per
ml)
B cell count (103 per ml)
NK cell count (103
per ml)

Sample (N ¼ 344)
Mean (SD)

Range

55
4.71 (2.2)
16.18 (1.4)
150.62 (4.2)
25.00 (3.5)
47.8

0.15–8.07
11.19–23.11
140.7–165.0
17.89–39.16

56.6
29.2
11.98 (4.3)
3.07 (1.5)
2.27 (1.3)

4.30–33.60
0.74–11.07
0.38–8.51

1.85 (1.0)

0.40–6.17

1.22 (0.7)

0.10–5.61

1.28 (0.8)
0.42 (0.3)

0.22–6.91
0.06–2.50

90

| Garcia et al.

University of California, Santa Barbara (#12-496) and the
University of New Mexico (#07-157). Adult participants provided informed consent for their own and their children’s participation. Children age six and older also provided verbal
assent.

2.1.3 Anthropometric and biomarker collection. Infant and
child height (or length) were measured by trained Tsimane research assistants using a portable Seca infantometer or stadiometer (Hamburg, Germany). For the purposes of analysis,
length and height were treated interchangeably. Weight was
measured using a Tanita digital scale to the closest tenth of a
kilogram. If infants were too small to stand on the scale, their
weight was calculated by subtracting the weight of the mother
from the combined weight of the mother holding her infant.
Maternal height and weight measures were collected using the
same instruments as used for the child, either at the same visit,
or within 30 days of the child’s visit. Tsimane-specific z-scores
for HAZ, child WHZ and maternal BMI-for-age (BMIZ) were calculated using the open-source R package localGrowth (https://
github.com/adblackwell/localgrowth), which utilizes growth
curves from [39]. These growth references better describe intrapopulation comparison by using locally-relevant growth trajectories [39]. Child WHZ and maternal BMIZ (in models for children under 3 years) were used as markers of energetic status, to
model the effects of interactions between child energetic status
and immune function on child HAZ. To determine the child’s
age, exact birthdates were verified by the mother or pulled from
longitudinal THLHP medical records.

2.1.3.1 Biomarker collection
Blood was collected by a certified Bolivian biochemist into a
heparin-coated vacutainer by venipuncture for children 2 years and
older, and by capillary heel or finger prick for infants under 2 years
of age [31]. Total WBC and hemoglobin were measured using a
QBC Autoread Plus dry hematology system (QBC Diagnostics)
directly after blood draw. Flow cytometry was performed in the
THLHP clinic in San Borja on fresh heparinized blood within six
hours of the blood draw in order to quantify lymphocyte subsets
into helper T cell (CD4þCD8), cytotoxic T cells (CD8þCD4),
NK cells (CD56þCD8CD4) and B cells (CD19þ) using an
Accuri C6 Flow Cytometer (BC Accuri Cytometers). T cells were
further classified as naı̈ve (CD45RAþ) or non-naı̈ve (CD45RA).
Absolute counts were calculated by multiplying the relative percentages determined by flow cytometer by the total lymphocyte count
obtained from the QBC Autoread Plus. For full description of gating and antibodies used [31].

2.1.3.2 Parasite analyses
Fecal samples were analyzed for the presence of helminth eggs
and larvae by direct identification on wet mounts or by a
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modified Percoll method [9, 40]. Parasite infection was recorded
as presence or absence of each species, and is based on a single fecal sample, collected and analyzed at the health clinic
within one day of blood collection.

2.2 Statistical analysis
Mixed effects models fit with restricted (residual) maximum likelihood (REML), from the R package lme4, were used to evaluate
relationships between markers of immune function and child
HAZ. Maternal ID was included as a random effect, as a means
to parse contribution of potential genetic clustering or clustering
due to immediate environment (e.g. shared household) from
individual-level factors that contribute to overall variation in HAZ
[41]. Effects of community-level clustering were also considered,
and initial models included community ID as a random effect.
However, since the inclusion of community ID did not substantially improve fit for any model, it was not included in final analyses. Height z-scores for mothers are also included in models, for
additional adjustment for potential heritable variation in height.
To adjust for variation in immune function based on current infection and associated immune activation, we include covariates for
respiratory illness and residual WBC counts. Additional models
were ran using the subset of the sample for whom fecal parasite
data were available (72% of sample), which include covariates for
current protozoal and helminthic infections assessed from fecal
samples. For each model, residual WBC count is WBC count
minus the portion of cells that were being used as the main independent variable of interest (e.g. in a model testing the association between total T cell count and height, residual WBC ¼ total
WBC  T cell count). This adjustment is necessary to minimize
collinearity. To measure relative investment in adaptive relative to
innate immunity, we calculate a ratio of adaptive (B and T) cells
to innate (NK) cells. Due to skewed distributions, all immune cell
counts are log-transformed and standardized (z-scored) before inclusion in regression models. All analyses were performed using
R statistical software version 3.4.2 [43]. All models adjust for age
and sex. All results are reported as standardized betas unless
otherwise noted. Both marginal and conditional R-squared values
are included in tables for linear mixed effects model results. While
marginal R-squared reflects the variance explained only by model
fixed effects, the conditional R-squared is interpreted to reflect
variance explained by both fixed and random effects (see Ref. [42]
for discussion of limitations on the use of these R-squared estimates in mixed effects models).

3. RESULTS
Children in this study ranged from 2 months to 8 years of age
(mean: 4.7 years, SD: 2.2) and 55% were female. Overall, 72% of
participants were screened for parasites. Of this sample, 57% of
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children were infected with at least one species of parasite, with
25.3% having coinfections with more than one species. The most
common infections were helminths, with hookworm (Ancylostoma
duodenale or Necator americanus, prevalence 50.6%) being most
common, followed by roundworm (Ascaris lumbricoides, 16.1%),
threadworm (Strongyloides stercoralis, 7.7%) and whipworm
(Trichuris sp., 2.3%). Protozoan infections were also common,
including Giardia lamblia (24.1%) and Entamoeba histolytica
(8.4%); further, 47.8% of children were diagnosed as having a
current respiratory condition. Using WHO criteria for age-specific
anemia cutoffs, 45.7% of children also had at least mild anemia
(<11 mg/dl of hemoglobin in children under age 5, and
<11.5 mg/dl for children aged 5–11 years).

3.1 Age-related changes in lymphocyte subsets

9000

6000

3000

3.2 Associations between adaptive immune function and
child height
Mixed effects linear regression models are used to evaluate relationships between child HAZ and markers of immune function,
with a random effect for mother’s ID (Fig. 2 and Table 2). HAZ
is consistently negatively associated with adaptive immune cell
counts after adjusting for age, sex, mother’s height, residual
WBC and current respiratory illness. Higher HAZ children have
lower overall T cells (b ¼ 0.37, P ¼ 0.001), including both
naı̈ve (b ¼ 0.15, P ¼ 0.009) and non-naı̈ve (b ¼ 0.16,
P ¼ 0.001) T cell counts, CD4þ (b ¼ 0.33, P ¼ 0.002) and
CD8þ (b ¼ 0.27, P ¼ 0.006) subsets (Fig. 2: Models 1–5) and
lower B cell counts (b ¼ 0.25, P ¼ 0.03; Model 6). There is no
association between innate (i.e. NK) cell counts and height (b
¼ 0.05, P ¼ 0.48; Model 7). Further, a higher ratio of adaptive
to innate immune cells is not associated with child height
(b ¼ 0.05, P ¼ 0.35) (Fig. 2: Model 8). Including maternal ID
significantly increased model fit across all models (Table 2),
suggesting that genetic and/or shared environmental factors influence variation in child HAZ.
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decline with age. Conversely, NK cells increase with age (b ¼
30.85, P < 0.001).

non−Naive
T−cells
non−Naive
T perper
µL µL

Naive T−cells per µL

Total T−cells per µL

We first examined overall differences in lymphocyte subsets by
age, adjusting for sex and current infections, fit with smoothed
loess curves based on generalized linear models (Fig. 1). Total
T cells (b ¼ 294.89 cells/ll of blood/year, P < 0.001) and all
subsets (naı̈ve: b ¼ 264.94, P < 0.001; non-naı̈ve: b ¼ 29.96,
P < 0.01; CD4þ: b ¼ 191.73, P < 0.001; CD8þ: b ¼ 103.19,
P < 0.001) and B cells (b ¼ 145.85, P < 0.001) significantly
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Figure 1. (a–g) Total T cells, including naı̈ve and non-naı̈ve, CD4 and CD8 subsets and B cells, significantly decline with age, while NK cells do not. The trendlines are loess fit (span ¼ 0.75)
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Age

Mother's height

Sex (male = 1)

Total T cells

Naive T cells
Model 1
Model 2
Model 3
Model 4
Model 5
Model 6
Model 7
Model 8

Non−naive T cells

CD4 cells

CD8 cells

B cells

NK cells

A:I ratio
−0.75

−0.50

−0.25

0.00

0.25

Coefficients
Figure 2. Trade-offs between child height and adaptive immunity. This figure compares parameter estimates of associations between measures of adaptive
immunity and child height across all adaptive immune models from Table 2. All immune markers were logged and standardized before analysis; A:I ratio is
the ratio of adaptive to innate immune cells, logged and standardized for analysis. Analyses include controls for age, mother’s height, sex and WBC (logged
and z-scored). *P < 0.05; **P < 0.01; ***P < 0.001

3.3 Height and immune associations by age group
Given children younger than 3 years are likely still supplemented
both immunologically and energetically by their mothers
through breastfeeding, the next set of analyses examines associations between HAZ and immune cell counts including an interaction with age group. For these analyses, children are split into
two groups: infants (children 2 months to 3 years; n ¼ 82) and
preadolescents (children 3–8 years; n ¼ 261). There are no significant associations between HAZ and immune cells across
cell types in infants (Table 3). In contrast, for preadolescents,
HAZ and total T cells (b ¼ 0.49, P < 0.001), both naı̈ve (b ¼
0.20, P ¼ 0.002) and non-naı̈ve (b ¼ 0.20, P < 0.001) T cell
counts, CD4þ (b ¼ 0.47, P < 0.001) and CD8þ (b ¼ 0.32,
P ¼ 0.004) T cell subsets, and B cells (b ¼ 0.34, P ¼ 0.006),
but not NK cells (b ¼ 0.03, P ¼ 0.73) or A:I ratio (b ¼ 0.10,
P ¼ 0.10) (Table 3). Because children traverse through numerous developmental phases even between 3 and 8 years of age,
we ran additional models which included a finer-grained agecategory variable, splitting children into approximately equally
weighted age groups (2 months to 3 years, n ¼ 82; 3–5 years,
n ¼ 91; 5–6.5 years, n ¼ 80; 6.5–8 years, n ¼ 90), and found that

these associations were strongest among the two middle
groups (3–5 and 5–6.5 years) (Supplementary Table S1).

3.4 maternal and child energetic status as a moderator of
immune-height trade-offs
To test the prediction that having adequate energetic reserves
may buffer a trade-off between immune function and growth in
the child, we examine the effects of a three-way interaction between each immune marker, child or maternal energetic status
and age group on child HAZ. In children under 3 years old, maternal energetic status (maternal BMIZ) moderates the relationship between total T (b ¼ 0.31, P ¼ 0.08) and CD4þ T cell
subsets (b ¼ 0.33, P ¼ 0.05), and the A:I ratio (b ¼ 0.19,
P ¼ 0.04) and height, but does not show any influence on immune cell counts and height relationships in preadolescents
(Supplementary Table S2). In other words, for infants whose
mothers have above the mean BMI, there is a positive association between cell count and HAZ, whereas for older children
(preadolescents), there remains a negative association between
cell count and HAZ, regardless of maternal BMI
(Supplementary Fig. S1). Alternately, models with child
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Table 2. Associations between immune function and child HAZ
Dependent variable: height (z-scored)
Total T
Cell countsa

0.372**
(0.115)
Age(in years)
0.058*
(0.025)
Sex(male ¼ 1)
0.038
(0.093)
0.294***
Mother’s heightb
(0.051)
0.218
Residual WBCc
(0.124)
Respiratoryd
0.125
(0.092)
Constant
1.572
(1.076)
Observations
344
Log Likelihood
442.31
0.13
R-squared (m)e
0.29
R-squared (c)f
Akaike Inf. Crit.
902.62
ANOVA table for random effect:
Log likelihood
445.44
Akaike Inf. Crit.
906.88
6.26*
LRTg

Naı̈ve
0.149**
(0.057)
0.053*
(0.026)
0.043
(0.094)
0.291***
(0.051)
0.181
(0.123)
0.135
(0.094)
1.251
(1.069)
343
443.89
0.12
0.28
905.77
Mother’s ID
447.05
910.10
6.32*

Non-naı̈ve

CD4þ

CD8þ

B cells

NK cells

A:I ratio

0.163**
(0.050)
0.032
(0.022)
0.016
(0.093)
0.287***
(0.051)
0.207
(0.123)
0.099
(0.094)
1.588
(1.078)
343
442.22
0.13
0.29
902.44

0.334**
(0.107)
0.056*
(0.025)
0.018
(0.093)
0.293***
(0.051)
0.214
(0.124)
0.135
(0.092)
1.535
(1.077)
344
442.68
0.12
0.29
903.37

0.269**
(0.096)
0.043
(0.024)
0.060
(0.094)
0.287***
(0.051)
0.163
(0.121)
0.113
(0.092)
1.156
(1.054)
344
443.76
0.12
0.28
905.53

0.254*
(0.115)
0.045
(0.026)
0.024
(0.094)
0.271***
(0.051)
0.169
(0.148)
0.101
(0.093)
1.227
(1.321)
344
445.12
0.11
0.27
908.24

0.053
(0.076)
0.008
(0.022)
0.030
(0.094)
0.279***
(0.051)
0.017
(0.137)
0.112
(0.093)
0.004
(1.279)
344
447.70
0.10
0.26
913.40

0.052
(0.056)
0.026
(0.025)
0.036
(0.094)
0.273***
(0.051)
0.009
(0.134)
0.112
(0.093)
0.267
(0.342)
344
447.79
0.10
0.26
913.58

445.48
906.95
6.51*

445.71
907.42
6.05*

446.90
909.80
6.27*

448.10
912.21
5.97*

450.8
917.6
6.20*

450.74
917.48
5.91*

Notes: REML regressions modeling associations between immune cell count and child HAZ. aAll immune measures are logged and standardized, bmaternal height is z-scored, cresidual WBC is fraction of WBC not included in cell count (e.g. for Mod 1, WBC ¼ total WBC – T cell count), z-scored,
d
clinician diagnosed respiratory infection (yes ¼ 1), emarginal r-squared represents the variance explained by the fixed effects, fconditional r-squared
represents the variance explained by both the fixed and random effects, glikelihood ratio test statistic.
*
P < 0.05; **P < 0.01; ***P < 0.001.

energetic status, measured by the child’s WHZ, show a different
pattern. For preadolescents (but not infants), there are interaction effects whereby WHZ status influences associations between height and total T cell (b ¼ 0.42, P < 0.005), naı̈ve (b ¼
0.23, P ¼ 0.001), CD4þ (b ¼ 0.41, P ¼ 0.002) and CD8þ cell
counts (b ¼ 0.25, P ¼ 0.06) (Table 4). Contrary to our predictions, the parameter estimates for these interaction terms are
negative: children with lower (i.e. below mean) WHZ show a
reduced association between adaptive immune function and
HAZ compared with high (i.e. above mean) WHZ children
(Fig. 3: total T cells). In fully adjusted models, high WHZ children are taller for their age compared to low WHZ children
(b ¼ 0.24, P ¼ 0.01; Supplementary Fig. 2), but do not differ
across measures of adaptive immune function (total T cells: b
¼ 0.03, P ¼ 0.53; naı̈ve: b ¼ 0.10, P ¼ 0.28; non-naı̈ve: b ¼
0.03, P ¼ 0.80; CD4: b ¼ 0.03, P ¼ 0.58; CD8: b ¼ 0.01,
P ¼ 0.86; or B cells: b ¼ 0.01, P ¼ 0.88). Child WHZ does not

directly predict differences in HAZ across any model
(Supplementary Table S3), and in fact lowers the model fit
(measured by R-squared). Again, in all models, mother’s height
and maternal ID have significant effects on child’s HAZ.

3.5 Influence of current parasitic infection on HAZ and
immune associations
Though in general, Tsimane children face relatively high exposure to parasites, variation in current infection may influence
physiological aspects of any particular child, including immune
cell repertoire and energetic status. Further, a child’s exposure
may also vary based on her/his age and stage of development.
As such, we conduct additional analyses on the subset of children in this sample for whom data on current infection was
available (n ¼ 246, 72% of total sample). Models include dichotomous covariates for (presence/absence of) helminthic
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Table 3. Associations between immune function and child HAZ by age group
Dependent variable: height (z-scored)

Age (in years)
Sex (male ¼ 1)
Mother’s height
Residual WBC
Respiratory
(yes ¼ 1)
Cell count:
3 years
and over
Cell count:
under
3 years
Constant
Observations
Log Likelihood
R-squared (m)
R-squared (c)
Akaike Inf. Crit.

Total T

Naı̈ve

Non-naı̈ve

CD4þ

CD8þ

B cells

NK cells

A:I ratio

0.048
(0.025)
0.044
(0.092)
0.291***
(0.051)
0.230
(0.123)
0.141
(0.092)
0.494***
(0.129)

0.041
(0.026)
0.048
(0.093)
0.287***
(0.052)
0.191
(0.123)
0.151
(0.094)
0.199**
(0.063)

0.027
(0.022)
0.022
(0.093)
0.286***
(0.051)
0.201
(0.123)
0.109
(0.094)
0.202***
(0.056)

0.046
(0.025)
0.018
(0.092)
0.288***
(0.051)
0.237
(0.124)
0.157
(0.092)
0.470***
(0.120)

0.038
(0.024)
0.067
(0.094)
0.285***
(0.051)
0.159
(0.121)
0.119
(0.093)
0.323**
(0.107)

0.032
(0.026)
0.027
(0.093)
0.273***
(0.051)
0.149
(0.148)
0.110
(0.092)
0.339**
(0.123)

0.005
(0.023)
0.028
(0.094)
0.276***
(0.052)
0.024
(0.138)
0.110
(0.093)
0.030
(0.085)

0.009
(0.027)
0.033
(0.094)
0.264***
(0.051)
0.001
(0.134)
0.115
(0.093)
0.103
(0.062)

0.025
(0.203)
1.749
(1.073)
344
440.75
0.14
0.31
901.49

0.003
(0.102)
1.423
(1.068)
343
443.56
0.12
0.30
907.12

0.038
(0.095)
1.567
(1.076)
343
442.34
0.13
0.30
904.68

0.045
(0.189)
1.818
(1.075)
344
440.43
0.14
0.31
900.85

0.087
(0.183)
1.159
(1.053)
344
443.77
0.12
0.29
907.54

0.055
(0.200)
1.134
(1.317)
344
444.00
0.12
0.28
908.00

0.134
(0.149)

0.109
(0.103)

0.082
(1.288)
344
448.38
0.10
0.26
916.76

0.125
(0.349)
344
447.32
0.11
0.27
914.64

Notes: REML regressions modeling interaction effects of immune cell count and age on child HAZ. Results are reported as beta coefficient (standard
error). Cell counts are logged and z-scored; Mother’s height is z-scored; Residual WBC is fraction of WBC not included in cell count (e.g. for Mod 1,
WBC ¼ total WBC – T cell count), z-scored. ‘Respiratory’ is a binary variable (yes ¼ 1) representing current respiratory illness, as diagnosed by a
physician at time of visit. R-squared (m) is the marginal r-squared and represents the variance explained by the fixed effects; R-squared is the conditional r-squared and represents the variance explained by both the fixed and random effects.
*
P < 0.05; **P < 0.01; ***P < 0.001.

parasites (hookworm, roundworm, threadworm, whipworm)
and protozoal parasites (G. lamblia and E. histolytica). In these
models, adjusting for helminthic and protozoal infections
strengthens inverse associations between immune cells and
HAZ across all cell types, except for the adaptive:innate ratio
(Supplementary Table S4). When binned by age group, adjusting for parasitic infections increases the statistical significance
of negative associations between all adaptive immune cells and
HAZ in preadolescence, and though it increases the effect size
across most cell types in infants, none reach statistical significance (Supplementary Table S5). Based on analysis of covariance models which adjust for age effects, neither helminthic
nor protozoal infection directly predicted differences in immune
cells or WHZ (Supplementary Table S6). However, infants are
significantly less likely to be infected by helminths, compared to
preadolescents (B ¼ 1.44, P < 0.001), but show no difference
in protozoal infection (B ¼ 0.32, P ¼ 0.31).

4. DISCUSSION
The aim of this study is to further our understanding of life history trade-offs between growth and immune function in early
childhood, and the potential role of energetic status (maternal
and child) in influencing these relationships. This study incorporates a diverse array of immune markers of specific immune
function, including lymphocyte subtypes (naı̈ve, non-naı̈ve and
total T cells, and CD4þ and CD8þ subtypes and B cells), and
the ratio of adaptive to innate (NK cells) immune cell counts as
a measure of longer-term allocations to immunity.
We find partial support for the hypothesis that a high pathogen environment should favor early investment in adaptive immune function, and that such heavy investment may trade-off
against somatic growth. In support of our first prediction,
higher counts of adaptive immune cells are associated with
shorter stature (measured by HAZ) across all T cell populations
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Table 4. Associations between immune function, WHZ, and child HAZ
Dependent variable: height (z-scored)

Age (in years)
Sex (male ¼ 1)
Mother’s height
Residual WBC
Respiratory
Cell count:
3 years þ:
child WHZ
Cell count:
<3 years:
child WHZ
Constant
Observations
Log Likelihood
R-squared (m)e
R-squared (c)f
Akaike Inf. Crit.

Total T

Naı̈ve

Non-naı̈ve

CD4þ

CD8þ

B cells

NK cells

A:I ratio

0.013
(0.022)
0.018
(0.094)
0.289***
(0.051)
0.063
(0.116)
0.113
(0.093)
0.419**
(0.149)

0.012
(0.021)
0.019
(0.093)
0.291***
(0.051)
0.062
(0.116)
0.112
(0.094)
0.236**
(0.072)

0.016
(0.022)
0.035
(0.095)
0.281***
(0.052)
0.075
(0.118)
0.103
(0.096)
0.026
(0.060)

0.015
(0.021)
0.016
(0.093)
0.286***
(0.051)
0.075
(0.116)
0.116
(0.093)
0.406**
(0.133)

0.013
(0.022)
0.031
(0.094)
0.286***
(0.051)
0.053
(0.117)
0.109
(0.093)
0.255*
(0.134)

0.012
(0.021)
0.032
(0.095)
0.289***
(0.052)
0.013
(0.130)
0.103
(0.093)
0.181
(0.119)

0.014
(0.021)
0.031
(0.094)
0.276***
(0.051)
0.004
(0.133)
0.112
(0.094)
0.042
(0.091)

0.014
(0.021)
0.024
(0.094)
0.281***
(0.051)
0.027
(0.134)
0.099
(0.094)
0.112
(0.065)

0.242
(0.168)

0.114
(0.081)

0.127
(0.091)

0.245
(0.162)

0.186
(0.158)

0.204
(0.153)

0.065
(0.137)

0.052
(0.084)

0.360
(1.025)
344
443.15
0.12
0.29
906.31

0.354
(1.023)
343
442.46
0.13
0.30
904.93

0.484
(1.037)
343
447.69
0.10
0.27
915.37

0.460
(1.022)
344
442.50
0.13
0.30
905.00

0.291
(1.034)
344
445.73
0.11
0.28
911.47

0.066
(1.183)
344
446.42
0.11
0.27
912.85

0.226
(1.232)
344
448.61
0.10
0.26
917.23

0.252
(0.340)
344
447.96
0.11
0.27
915.91

Notes: REML regressions modeling three-way- interaction effects of immune cell count, age, and child energetic status (proxied by WHZ) on child
HAZ. Results are reported as beta coefficient (standard error). Cell counts are logged and z-scored; Mother’s height is z-scored; Residual WBC is fraction of WBC not included in cell count (e.g. for Mod 1, WBC ¼ total WBC – T cell count), z-scored. ‘Respiratory’ is a binary variable (yes ¼ 1) representing current respiratory illness, as diagnosed by a physician at time of visit. R-squared (m) is the marginal r-squared and represents the variance
explained by the fixed effects; R-squared is the conditional r-squared and represents the variance explained by both the fixed and random effects.
*
P < 0.10; **P < 0.05; ***P < 0.01; ***P < 0.001.

and B cells. Associations are further strengthened when adjusting for current parasitic infection. These findings complement
experimental work from animal literature as well as research
among human populations living in high pathogen environments. For example, magpies that were given methionine, a sulfur amino acid that enhances T cell immune response,
exhibited less growth over the course of treatment than controls
[44]. In humans, other research among the Tsimane, and the
Shuar of Ecuador, both of which face relatively high parasite
loads, reports consistent growth and immune function tradeoffs. In both populations, inverse associations are found between markers of adaptive and innate immune function with
both cross-sectional HAZ and longitudinal growth. Higher levels of immunoglobulin E, a measure of adaptive humoral immune and indicator of past exposure to parasites, was
associated with lower HAZ scores [9], while higher levels of C-

reactive protein were associated with reduced longitudinal
growth [17]. Further, among the Shuar, immunoglobulin G and
C-reactive protein were also inversely associated with longitudinal growth [10].
That both naı̈ve and non-naı̈ve T cells similarly negatively associate with HAZ in our sample suggests that growth–immune
trade-offs are not strictly due to past exposures. Naı̈ve T cells
have not yet encountered antigens, and reduced cell counts
might represent past exposures, if exposure converts naı̈ve to
non-naı̈ve cells. However, if this were the case, we would expect
a positive association between T cells and height, assuming infection itself is costly. In contrast, higher naı̈ve T cell counts are
likely to represent investment in immune defenses for threats
that have not yet been encountered. The fact that both cell types
associate negatively with height, even in models that adjust for
current parasitic infection, suggests that trade-offs with height
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Figure 3. Graphical display of results from Table 4, model 1. For children 3 years and older, there is a negative interactive effect of child WHZ on the association between total T cell count and height. There appears to be a height-immune trade-off only in children that are at or above the mean for WHZ. Note: child
height and WHZ are z-scored, and total T cell count is logged and z-scored for analyses. Model controls for age, sex, mother’s height and current immune activation, and a random effect for maternal ID

are likely due to overall investment in cellular immunity and are
not necessarily dependent on the causes of that investment (i.e.
responsive vs. predictive). These associations suggest that it is
the immune investment itself may trade-off with height, rather
than direct costs of past infections.
Though in the full sample there are negative associations between adaptive immune markers and HAZ, when children are
split into age-groups: infants (< 3 years old) and preadolescents (3-8 years old), cell counts and HAZ associations we find
that are not statistically significant in the younger age group.
The lack of an association between HAZ and immune function
in infants may be due to a few statistical or biological facets.
Statistically, because coefficients were consistently negative (as
in the older group) after adjusting for current immune activation, the lower sample size and higher error in this group may
have obscured any statistical significance in associations from
emerging. Biologically, it may be that infants maintain adequate
buffering by maternal energetic and immunologic resources,
transmitted via breastfeeding, through this time period. In accordance with this idea, we do find a positive interaction between mother’s energetic status and associations between
immune cell counts and HAZ among infants whereby children
with higher-BMI moms show a positive association between
height and immune cell counts. There is a rich literature

showing growth faltering after weaning, which may be a consequence of increased exposure to contaminants and other environmental pathogens [45–47]. In fact, we do see that
preadolescents are more likely to have helminthic parasites
compared to infants, and, that protozoal infection is positively
associated with greater WHZ, which in infants may be evidence
of earlier weaning. Though we do not have systematic quantitative data on breastfeeding status and intensity for the present
sample, a different Tsimane study found that children breastfeed until between 30-36 months of age, in concert with the
introduction of complementary foods [48].
However, another possibility is that the lack of associations
could be due to heterogeneity in maturational pace among individuals in this age group. For example, children who are
maturationally delayed overall, would be smaller and likely have
higher naı̈ve immune cell counts. Growth is not continuous,
and it is therefore difficult to confidently assess the impact of
current immune profiles on growth using cross-sectional measures. It is likely that there are coordinated developmental
changes across these various systems (height, weight, immune
status) that vary by both chronological and maturational age
which obscure our ability to tease apart trade-offs from shifts in
coordination. In these data, we found that in fact the largest effect sizes for associations between immune cells and HAZ was
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among those aged 3–6.5 years old. However, given the relatively
small sample sizes in each age category, a deeper evaluation of
coordinated shifts among physiological systems across age was
out of the scope of this article. Additional research with larger
sample sizes are needed to fully address this issue.
Regarding our last prediction, we found that among preadolescents, child energetic status (WHZ) did moderate associations
between HAZ and immune cell counts across all T-cell subtypes,
and that inverse associations between all adaptive cell types and
height are strengthened after accounting for interactive effects of
WHZ and immune markers. However, contrary to our prediction,
the direction of the interaction term was negative. In graphing
these interactions, we found that negative height and immune
associations are more significant in children with higher nutritional status. At the proximal level, this is likely explained by the fact
that lower WHZ children are, on average, shorter for their age
than high WHZ children, but do not show differences across
measures of adaptive immune function.
That children with reduced nutritional status are shorter but
have similar adaptive immune profiles may allude to a ‘lower
threshold’ for investment in adaptive immune function that is
critical for survival in high pathogen environments which must
be maintained in the face of energetic constraints. Thus, additional resources might be invested in height, but not at a cost
to meeting the baseline for adequate adaptive immune function. Though we cannot conclude this from the current data,
this speculation fits well within the immunology literature that
posits an optimality in bounded, or ‘intermediate’, variation in
components of pathogen recognition systems like MHC complexes [49]. Similarly in evolutionary ecology, a number of studies have documented population-level variation in immunerelated traits driven by ecological pressures like pathogen diversity, which may vary spatially [50] and seasonally [51]; for a review see [52]. Studies among the Tsimane have also
consistently found upregulation in most components of immune function relative to ‘standard cutoffs’ in the U.S., and directly compared to populations under less pathogen exposure,
including from the U.S. and Ecuador ([36]; [53]). It is important
to note that this is not the same idea as ‘phenotypic correlation’—which suggests that a positive correlation between two
traits can occur when individuals with plentiful resources can allocate excess quantities to both traits [54]. In fact, this idea is
complementary by suggesting that there may be a relatively stable lower limit to the level of investment in immune function
that must be met to ensure survival, which should be dependent on ecological context and likely differ across populations.
However, an alternate interpretation is that pathogenicallystressed or ill children may eat less or absorb less nutrients,
which may have effects on growth and immune function. In
such cases, children may show growth faltering [55, 56], and
greater immune responsivity, yet have overall attenuated immune function [57]. While this could plausibly explain some
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variation in height and immune function, the findings reported
here hold after the inclusion of numerous covariates to adjust
for differences in current pathogen exposure and immune activation, and thus we argue that adding an evolutionary perspective to this question is important for expanding how we think
about variation in life history traits and health.
Finally, we find significant fixed and random effects of variables that capture genetic and shared environmental factors (e.g.
maternal height and ID, and current parasitic infection). Across
most models, conditional R-squared, which represents the variance explained by both fixed effects and a random effect for maternal ID captures roughly 10% more variance in HAZ than
fixed effects alone. Further, models that adjust for maternal factors and parasitic infection capture over 30% of variation in
HAZ scores across all models. These findings point to a confluence of factors that interact and influence height differences between children, and highlight the fact that growth and immune
trade-offs, while possible, are nowhere near zero-sum.

Limitations
Though we believe this study is novel in its application of ecological immunology to inform our understanding of trade-offs
between growth and immunity, we are cautious about making
strong inferences. We recognize that a cross-sectional study design limits our ability to establish causality, and tease apart
short-term trade-offs versus longer-term phenotypic adjustments, such as a predictive adaptive response [58]. Further,
there may be issues with using WHZ as a proxy for energetic
status, given that these measures do not adequately reflect variation in fat-free body mass from body fat. Higher activity level
(and thus muscle mass and WHZ) may also reduce energy
available for growth, in addition to the costs of immune function. Though this is not necessarily the case, this possibility
cannot be ruled out. Along the same vein, both growth and energy reserves may not be stable over time, particularly during
early windows of development. However, the child populationspecific growth curves for the Tsimane have relatively constant
WHZ velocities until around the age of 10 years [39].

5. CONCLUSION AND IMPLICATIONS
Tracking trade-offs between growth and immune function is
enormously complex, particularly due to the changing relationships between distribution of body fat and mass relative to
height, and shifts in allocation between life history traits, that
occur during this period of active growth and development as
growing bodies attempt to calibrate optimally to their projected
environment. In this study, we find that among children in a
high-pathogen environment, greater investment in aspects of
adaptive immune function is negatively associated with HAZ.

98

| Garcia et al.

Child energetic status appears to moderate this association,
and the strongest negative associations are found in older children with higher nutritional status. Children with lower WHZ
are shorter but retain high investment in adaptive immunity,
indicating the biological significance of maintaining a robust
adaptive immune system even under energetic constraints.
Reduced investment in growth in favor of immunity may be necessary for survival in high pathogen contexts. Further, genetic
and (shared) environmental factors are important considerations for understanding variation in height within this population. The implications of these findings may be important for
prompting a reconsideration of how height is used as a marker
of health. Given the high plasticity and variable heritability in
height, in conjunction with the cost and utility of immune function across environments, stature may not be a universally
equitable metric for predicting health.

Evolution, Medicine, and Public Health
5. McDade TW, Georgiev AV, Kuzawa CW. Trade-offs between acquired
and innate immune defenses in humans. Evol Med Pub Health 2016;
2016:1–16.
6. Zuk M, Stoehr AM. Immune defense and host life history. Am Nat
2002;160:S9-S22. doi:10.2307/3079266.
7. Crimmins EM, Finch CE. Infection, inflammation, height, and longevity.
Proc Natl Acad Sci 2006;103:498–503.
8. Luke A, Guo X, Adeyemo AA et al. Heritability of obesity-related traits
among Nigerians, Jamaicans and US Black People. Int J Obes Relat
Metab Disord 2001;25:1034–41.
9. Blackwell AD, Snodgrass JJ, Madimenos FC, Sugiyama LS. Life history,
immune function, and intestinal Helminths: trade-offs among immunoglobulin E, C-reactive protein, and growth in an Amazonian population. Am J Hum Biol 2010;22:836–48.
10. Urlacher SS, Ellison PT, Sugiyama LS et al. Tradeoffs between immune
function and childhood growth among Amazonian forager-horticulturalists. Proc Natl Acad Sci U S A 2018;115:E3914–21.
11. Campbell DI, Elia M, Lunn PG. Growth faltering in rural gambian
infants is associated with impaired small intestinal barrier function,

SUPPLEMENTARY DATA
Supplementary data is available at EMPH online.

leading to endotoxemia and systemic inflammation. J Nutr 2003;133:
1332–8.
12. Miller EM, McConnell DS. Brief communication: chronic undernutrition
is associated with higher mucosal antibody levels among ariaal infants
of Northern Kenya. Am J Phys Anthropol 2012;149:136–41.

acknowledgments
We thank the Tsimane people, and our great THLHP team for facilitating
this research. We are grateful to Chris Kuzawa and Dan Cummings for
their helpful suggestions and comments. We thank the reviewers for their
important insights and critiques, and appreciate the strengths they have
brought to this manuscript.

13. Panter-Brick C, Lunn PG, Langford RM et al. Pathways leading to early
growth faltering: an investigation into the importance of mucosal damage and immunostimulation in different socio-economic groups in
Nepal. Br J Nutr 2008;101:558–67.
14. Taborsky B. Developmental plasticity: preparing for life in a complex
world. Adv Stud Behav 2017;49:49–99.
15. Stephensen CB. Burden of infection on growth failure. symposium:
‘cause and etiology of stunting’, April 1998. J Nutr Acad Res Lib 1999;
129:534S–8S.
16. Kuzawa CW. Adipose tissue in human infancy and childhood:

funding

an evolutionary perspective. Am J Phys Anthropol 1998;Suppl 27:177–209.
17. McDade TW, Reyes-Garcı́a V, Tanner S et al. Maintenance versus

We thank the National Institute for Aging (NIH/NIA RF1AG054442) for the

growth: investigating the costs of immune activation among children

funding that allowed this research to be possible. J.S. acknowledges IAST

in Lowland Bolivia. Am J Phys Anthropol 2008;136:478–84.
18. Searle SR. Phenotypic, genetic and environmental correlations.

funding from the French National Research Agency (ANR) under grant
ANR-17-EURE-0010 (Investissements d’Avenir program).

Biometrics 1961;17:474–80.

Conflict of interest: None declared.

19. Parham P. The Immune System. New York, USA: Garland Science, 2014.
20. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate

references

21. Kindt TJ, Goldsby RA, Osborne BA, Kuby J. Kuby Immunology. New
York, USA: Macmillan, 2007.

immune system. Science 2010;327:291–5.
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